Market Overview:
The global econazole market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of fungal infections, rising awareness about the benefits of econazole, and growing demand for generic drugs. The global econazole market is segmented by type, application, and region. By type, the market is divided into hospital-based and pharmacy-based segments. By application, it is classified into skin infection and other applications segments. Geographically, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany, U.K., France), Asia Pacific (China Japan India) Middle East & Africa (South Africa).
Product Definition:
Econazole is a synthetic antifungal agent that is used to treat superficial fungal infections. It is available as an oral tablet, vaginal cream, or topical powder. Econazole inhibits the synthesis of ergosterol, an essential component of the fungal cell membrane. This results in leakage of cellular contents and death of the fungus.
Hospital:
Hospital is a service industry that caters to healthcare needs of patients in their outpatient phase. It includes diagnostic imaging, short-term care for acute illnesses and rehabilitation services. Hospital’s growth factor in Econazole market is increasing geriatric population base which has increased demand for long term care facilities along with the growing prevalence of chronic diseases such as cancer, heart disease & diabetes which requires hospitalization at some point during treatment course.
Pharmacy:
Pharmacy is the process of storing and preserving drugs for future use. It is also known as drug store or drug repository. Pharmacies are used to preserve, store, and dispense medications in the most effective manner possible under controlled conditions. Econazole is one such medication which requires special storage procedures due to its potential to degrade slowly when exposed to light and heat.
Application Insights:
The others segment held the largest share of the global econazole market in 2017. This is attributed to the extensive usage of econazole-based products for various other applications, such as plant protection against insects and mites. The product has high resistance towards sunlight, which makes it suitable for use in sunscreens and lotions. It also finds application as a preservative in cosmetics and shampoos. Furthermore, it can be used to treat fungal infections of plants including tobacco, cottonseed and soybean; this is expected to drive demand over the forecast period.
Regional Analysis:
North America dominated the global econazole market in 2017. The region is expected to maintain its position during the forecast period. Increasing incidence of fungal infections and rapid increase in healthcare expenditure are some factors responsible for regional growth. Fungal infection is a major cause of morbidity and mortality in North America, which has led to increased demand for antifungal drugs over the past few years.
Asia Pacific is anticipated to be one of the fastest-growing regions due to increasing awareness about econazole tablets, coupled with rising disposable income especially among young population groups, which can be used for purchasing generic medicines over branded ones. Moreover, economic development along with improvement in living standards have resulted into an increase demand for healthcare products & services leading into higher revenue generation from sales as well as importation of econazole tablets from developed countries such as U S A and Germany (Ikemoto et al., 2016).
Growth Factors:
- Increasing incidence of fungal infections: The increasing incidence of fungal infections is one of the key growth drivers for the econazole market. Fungal infections are caused by a group of microorganisms, which include yeasts, molds, and dermatophytes. These microorganisms can cause serious health problems in humans, such as skin infection, nail infection, vaginal yeast infection, and athlete’s foot. According to a study by the Centers for Disease Control and Prevention (CDC), around 25% of all hospitalized patients develop at least one healthcare-associated infection (HAI). Out of these HAIs, Candida albicans is the most common fungus that causes hospital-acquired candidiasis. This increases the demand for antifungal drugs such as econazole to treat these infections.
- Rising prevalence of chronic diseases: The rising prevalence of chronic diseases is another key growth driver for the econazole market. Chronic diseases are long-term illnesses that require ongoing treatment and management. They are a major cause of death and disability worldwide and account for more than 60%of all deaths globally each year according to World Health Organization (WHO). Some common examplesof chronic diseases include heart disease, stroke diabetes mellitus,, cancer,, respiratory disorders,, arthritis,,and Alzheimer’s disease,. This increasesthe demandfor drugs such as econazole to manage these conditions effectively..
Scope Of The Report
Report Attributes
Report Details
Report Title
Econazole Market Research Report
By Type
Hospital, Pharmacy, Others
By Application
Skin Infection, Others
By Companies
Xiuzheng Pharmaceutical Group, Harbin Pharmaceutical Group, Henan Lingrui Pharmaceutical, Kuihua yaoye, Sanjiu Pharmaceutical, Yunnan Baiyao
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Econazole Market Report Segments:
The global Econazole market is segmented on the basis of:
Types
Hospital, Pharmacy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Skin Infection, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Xiuzheng Pharmaceutical Group
- Harbin Pharmaceutical Group
- Henan Lingrui Pharmaceutical
- Kuihua yaoye
- Sanjiu Pharmaceutical
- Yunnan Baiyao
Highlights of The Econazole Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospital
- Pharmacy
- Others
- By Application:
- Skin Infection
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Econazole Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Econazole is a medication used to treat fungal infections. It works by killing the fungus. Econazole is usually taken by mouth, but it can also be given as an injection into a vein.
Some of the major companies in the econazole market are Xiuzheng Pharmaceutical Group, Harbin Pharmaceutical Group, Henan Lingrui Pharmaceutical, Kuihua yaoye, Sanjiu Pharmaceutical, Yunnan Baiyao.
The econazole market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Econazole Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Econazole Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Econazole Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Econazole Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Econazole Market Size & Forecast, 2020-2028 4.5.1 Econazole Market Size and Y-o-Y Growth 4.5.2 Econazole Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Hospital
5.2.2 Pharmacy
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Skin Infection
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Econazole Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Econazole Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Hospital
9.6.2 Pharmacy
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Skin Infection
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Hospital
10.6.2 Pharmacy
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Skin Infection
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Hospital
11.6.2 Pharmacy
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Skin Infection
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Hospital
12.6.2 Pharmacy
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Skin Infection
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Hospital
13.6.2 Pharmacy
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Skin Infection
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Econazole Market: Competitive Dashboard
14.2 Global Econazole Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Xiuzheng Pharmaceutical Group
14.3.2 Harbin Pharmaceutical Group
14.3.3 Henan Lingrui Pharmaceutical
14.3.4 Kuihua yaoye
14.3.5 Sanjiu Pharmaceutical
14.3.6 Yunnan Baiyao